Tech Company Financing Transactions

NephroGenex Funding Round

On 6/30/2008, NephroGenex landed $22 million in funding from Care Capital, Rho Ventures and private investors.

Transaction Overview

Company Name
Announced On
6/30/2008
Transaction Type
Venture Equity
Amount
$22,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
3200 Beechleaf Ct. 900
Raleigh, NC 27604
USA
Email Address
Overview
NephroGenex (NASDAQ: NRX) is a biotechnology company applying the latest advances in molecular profiling technologies to unravel the complex pathologies found in kidney disease.
Profile
NephroGenex LinkedIn Company Profile
Social Media
NephroGenex Company Twitter Account
Company News
NephroGenex News
Facebook
NephroGenex on Facebook
YouTube
NephroGenex on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Peter Isdale
  Peter Isdale LinkedIn Profile  Peter Isdale Twitter Account  Peter Isdale News  Peter Isdale on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2008: AirPlay Network venture capital transaction
Next: 6/30/2008: MarkMonitor venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary